These findings suggested that the numbers of SMN2 copies are not functionally equivalent among patients with SMA [85], or other genetic modifiers outside of SMN2 may contribute to the progression of the disease [11]. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.